The Walter Reed Army Institute of Research (WRAIR) has conducted a first-in-human evaluation of a novel malaria vaccine candidate containing the FMP013 antigen and the ALFQ adjuvant, both developed at WRAIR. Results were published August 30 in the journal Vaccine.
Mbeya, Tanzania – The Walter Reed Program-Tanzania (WRP-T) recently participated in the agricultural trade fair celebrating the “Nane Nane” public holiday recognizing the contributions of farmers. WRP-T's ’s exhibition at the fair highlighted WRP-T's HIV program interventions, the DREAMS initiative for adolescent girls and young women, and even offered COVID-19 vaccinations on site.
Tanzania’s agriculture minister, Hussein Bashe, expressed support for a group of adolescent girls and young women (AGYW) from the Kyela region to help them set up a cocoa farm as part of their entrepreneurship project under the Walter Reed Program-Tanzania (WRP-T) DREAMS program.
Tanzania Prime Minister Kassim Majaliwa commended the Walter Reed Program-Tanzania (WRP-T) medication-assisted treatment (MAT) initiative to help people who use or injects. The MAT program follows harm reduction strategies, providing clients with medications in combination with counseling and behavioral therapies while also fighting HIV, TB and hepatitis B and C.